<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36856">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01942421</url>
  </required_header>
  <id_info>
    <org_study_id>639/2551(EC2)</org_study_id>
    <nct_id>NCT01942421</nct_id>
  </id_info>
  <brief_title>Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation</brief_title>
  <official_title>Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <authority>Thailand: Ethical Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to elucidate the appropriate condition of  developing
      cultivated autologous oral mucosal epithelial graft and evaluate the surgical outcome of
      transplantation of the cultivated cells in the patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ocular surface damage caused by severe ocular surface diseases. Corneal limbal stem cell
      transplantation has been demonstrated to improve the outcome of ocular surface
      reconstruction. However, the conventional management of allograft limbal transplantation
      generally has unsatisfactory outcome because of high risk of rejection and requires
      long-life immunosuppressive medications. Ocular surface reconstruction with cultivated
      autologous mucosal epithelial transplantation is served to improve the surgical results of
      ocular surface reconstruction and decrease the use of immunosuppressive medications
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Ocular surface clinical and pathological status(signs of limbal deficiency and immunopathological markers)after the surgery</measure>
    <time_frame>Three years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Ocular Surface Disease</condition>
  <arm_group>
    <arm_group_label>Cultivated mucosal epithelial transplant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cultivated mucosal epithelial transplantaion to limbal deficiency patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cultivated mucosal epithelial transplantation</intervention_name>
    <description>cultivated autologous mucosal epithelium, then transplant to limbal stem cell deficiency patients.</description>
    <arm_group_label>Cultivated mucosal epithelial transplant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral limbal stem cell deficiency proved by specific clinical features and
             impression cytology

        Exclusion Criteria:

          -  Age under 18

          -  Active ocular infection, Severe dry eye, Uncontrolled glaucoma

          -  Immunocompromised host

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pinnita Prabhasawat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pinnita Prabhasawat, MD</name>
      <address>
        <city>Bangkok</city>
        <zip>10300</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 10, 2013</lastchanged_date>
  <firstreceived_date>December 6, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Pinnita Prabhasawat</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Limbal deficiency</keyword>
  <keyword>Cultivated limbal transplantation</keyword>
  <keyword>Ex vivo limbal transplantation</keyword>
  <keyword>Cultivated autologous mucosal epithelial transplantation</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
